EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in patients with hematological malignancies from 2014 to 2022

Meng Li, Liyan Ye, Zhenghao Yu, Hongwu Yao, Yunxi Liu, Guanglei Wang, Mingmei Du

Frontiers in Microbiology · 07.01.2025 · 15

DOI: 10.3389/fmicb.2024.1507908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 07.01.2025. Verfasst von Meng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Medical Center of Chinese PLA General Hospital, Beijing, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to describe the epidemiology, cross-transmission, interventions, and outcomes of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in the hematological malignancies (HM) department of a hospital in China.

Methods

This prospective study was divided into three stages from 2014 to 2022: Period 1 (from 1 January 2014 to 4 March 2021), Period 2 (from 5 March 2021 to 31 December 2021), and Period 3 (from 1 January 2022 to 31 December 2022), with different measures implemented at each stage to evaluate the rate of new infections. The risk factors, epidemiological characteristics, data from all patients with CRKP, NGS gene sequencing molecular epidemiology analysis, and cross-transmission were described.

Results

A total of 217 patients with K. pneumoniae isolates, including 38 (17.5%) patients with CRKP isolates, were confirmed in the HM department. The total rate of CRKP in KP isolates was 17.5%. The predominant clone in the HM department was ST11 CRKP producing the KPC-2 enzyme (21, 70.0%). A total of 23 cases of HM department-acquired CRKP infections were identified, and five hospital cross-transmission events were observed. Four instances of CRKP dissemination were primarily related to clone ST11. Only one outbreak occurred at the end of Period 1, involving four cases of CRKP healthcare-associated infections (HAIs). After the implementation of outbreak intervention bundles at the end of Period 2, no cross-transmission occurred. The rate of CRKP in KP isolates decreased to 12.9% (only four CRKP isolates) in Period 3, down from a peak of 46.7% in Period 2 (including 14 CRKP isolates). Only one new carrier (0.9%) was identified during the two cross-sectional active screenings of the rectal swab. The 28-day mortality rate was 38.7% (12/31) in CRKP-infected patients.

Conclusion

The prevalence of CRKP in the HM department was relatively low in the studied hospital. We found that interventions, including single-room isolation, enhanced disinfection, and skin decolonization, played a pivotal role in controlling the spread of HM-acquired CRKP infections.

Schlagwörter

Stichwörter der Autor:innen

Klebsiella pneumoniaecarbapenem-resistantepidemiologyhematological malignanciesinfections

Autor:innen und Institutionen

  • Department of Hematology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Department of Laboratory Medicine, The First Medicine Center of Chinese PLA General Hospital, Beijing, China.
  • Health Management Institute, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
  • Department of Infection Management and Disease Control, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Ministry of Guards, The First Medical Center of Chinese PLA General Hospital, Beijing, China.

Zitieren

APA

Li, M., Ye, L., Yu, Z., Yao, H., Liu, Y., Wang, G., & Du, M. (2025). Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in patients with hematological malignancies from 2014 to 2022. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1507908

Vancouver

Li M, Ye L, Yu Z, Yao H, Liu Y, Wang G, et al. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in patients with hematological malignancies from 2014 to 2022. Frontiers in Microbiology. 2025;15. doi:10.3389/fmicb.2024.1507908

BibTeX
@article{Li2025,
  author = {Li, Meng and Ye, Liyan and Yu, Zhenghao and Yao, Hongwu and Liu, Yunxi and Wang, Guanglei and Du, Mingmei},
  title = {Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in patients with hematological malignancies from 2014 to 2022},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fmicb.2024.1507908}
}
Kostenlos starten →